Back to search

Article

Obesity medication lorcaserin requires brainstem GLP-1 neurons to reduce food intake in mice

2022-05-06

Abstract excerpt

Overweight and obesity are rapidly becoming the “new normal” in developed countries, which promotes a widespread negative impact on human health. Amongst recently developed obesity medications are the serotonin 2C receptor (5-HT 2C R) agonist lorcaserin and glucagon-like peptide-1 receptor (GLP-1R) agonists, but the brain circuits employed by these medications to produce their therapeutic effects remain to be ful...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f45e0bf3-f7a0-5bc9-b82f-2c94f22cb4db
DOI
10.1101/2022.05.06.490598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Obesity medication lorcaserin requires brainstem GLP-1 neurons to reduce food intake in miceDOI 10.1101/2022.05.06.490598
Select a neighboring publication to make it the new centre.